| Literature DB >> 35744016 |
Chih-Chun Hsiao1, Yao-Ming Huang2, Yin-Han Chang3, Hui-Chen Lin4, Wu-Chien Chien5,6,7, Chun-Gu Cheng2,8,9,10, Chun-An Cheng11.
Abstract
Background andEntities:
Keywords: ischemic heart disease; risk; septicemia survivors
Mesh:
Year: 2022 PMID: 35744016 PMCID: PMC9230713 DOI: 10.3390/medicina58060753
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.948
Figure 1The flowchart of this study.
Figure 2Kaplan–Meier curve for the cumulative incidence of ischemic heart disease. It was stratified by new-onset atrial fibrillation with a log-rank test of p < 0.001.
Baseline characteristics of the study subjects.
| MACEs (853) | MACEs Free (3470) |
| |
|---|---|---|---|
| New-onset atrial fibrillation | 28 (3.28%) | 39 (1.12%) | <0.001 * |
| Age | 67.6 ± 15.05 | 58.19 ± 18.89 | <0.001 * |
| Gender (male) | 503 (58.97%) | 1780 (51.3%) | <0.001 * |
| Hypertension | 276 (32.36%) | 1273 (36.69%) | 0.019 * |
| Diabetes mellitus | 301 (35.29%) | 1185 (34.15%) | 0.546 |
| Congestive heart failure | 35 (4.1%) | 62 (1.79%) | <0.001 * |
| Hyperlipidemia | 30 (3.52%) | 213 (6.14%) | 0.002 * |
| Chronic kidney disease | 219 (25.67%) | 543 (15.65%) | <0.001 * |
| Chronic obstructive pulmonary disease | 222 (26.03%) | 771 (22.22%) | 0.02 * |
| Peripheral aretery obstructive disease | 4 (0.47%) | 18 (0.52%) | 1 |
| Cancer | 183 (21.45%) | 180 (5.19%) | <0.001 * |
| Infection type | |||
| Pneumonia | 173 (20.28%) | 468 (13.49%) | <0.001 * |
| Urinary tract infection | 230 (27%) | 1065 (30.69%) | 0.033 * |
| Skin infection | 34 (3.99%) | 234 (6.74%) | 0.002 * |
| GI infection | 30 (3.52%) | 248 (7.15%) | <0.001 * |
| Hospital type | 0.877 | ||
| Medical center | 303 (35.55%) | 1201 (34.61%) | |
| Regional hospital | 340 (39.86%) | 1397 (40.26%) | |
| Local hospital | 210 (24.61%) | 872 (25.13%) | |
| Area | 0.233 | ||
| Northern Taiwan | 346 (40.56%) | 1485 (42.8%) | |
| Central Taiwan | 218 (25.57%) | 853 (24.58%) | |
| SouthernTaiwan | 223 (26.14%) | 929 (26.77%) | |
| Eastern Taiwan | 64 (7.5%) | 193 (5.56%) | |
| Outlying islands | 2 (0.23%) | 10 (0.29%) | |
| Organ failure | |||
| Respiratory failure | 196 (22.98%) | 339 (9.77%) | <0.001 * |
| Circulatory failure | 82 (9.61%) | 242 (6.97%) | 0.011 * |
| Renal failure | 89 (10.43%) | 186 (5.36%) | <0.001 * |
| Neurologic failure | 13 (1.52%) | 50 (1.44%) | 0.873 |
| Hepatic failure | 29 (3.4%) | 68 (1.96%) | 0.014 * |
| Metabolic failure | 7 (0.82%) | 12 (0.35%) | 0.078 |
| Hematologic failure | 17 (2%) | 68 (1.96%) | 0.891 |
* p < 0.05; MACEs: major adverse cardiovascular events.
Risk factors for major adverse cardiovascular events in septicemia survivors.
| Risk Factors | Hazard Ratio(95% Confidence Interval) |
|
|---|---|---|
| New-onset atrial fibrillation | 1.705 (1.156–2.516) | 0.007 * |
| Age | 1.03 (1.025–1.035) | <0.001 * |
| Gender (male) | 1.334 (1.153–1.543) | <0.001 * |
| Hypertension | 0.631 (0.541–0.737) | <0.001 * |
| Diabetes mellitus | 1.11 (0.954–1.291) | 0.177 |
| Congestive heart failure | 1.52 (1.073–2.154) | 0.018 * |
| Hyperlipidemia | 0.802 (0.554–1.16) | 0.241 |
| Chronic kidney disease | 1.53 (1.298–1.804) | <0.001 * |
| Chronic obstructive pulmonary disease | 1.297 (1.094–1.538) | 0.003 * |
| Hospital type | 0.304 | |
| Medical center | reference | |
| Regional hospital | 0.999 (0.844–1.181) | 0.987 |
| Local hospital | 1.136 (0.939–1.373) | 0.189 |
| Area | 0.028 * | |
| Northern Taiwan | reference | |
| Central Taiwan | 1.196 (1–1.431) | 0.05 * |
| Southern Taiwan | 1.125 (0.948–1.335) | 0.176 |
| Eastern Taiwan | 1.537 (1.166–2.027) | 0.002 * |
| Outlying islands | 1.635 (0.402–6.643) | 0.509 |
| Pneumonia | 1.176 (0.978–1.416) | 0.085 |
| Urinary tract infection | 0.862 (0.732–1.015) | 0.075 |
| Skin infection | 0.704 (0.496–0.997) | 0.048 * |
| GI infection | 0.509 (0.352–0.736) | <0.001 * |
| Respiratory failure | 1.852 (1.549–2.215) | <0.001 * |
| Circulatory failure | 0.948 (0.779–1.29) | 0.908 |
| Renal failure | 1.806 (1.434–2.274) | <0.001 * |
| Neurological failure | 0.784 (0.45–1.365) | 0.39 |
| Cancer | 3.578 (3.014–4.246) | <0.001 * |
| Hepatic failure | 1.593 (1.091–2.328) | 0.016 * |
| Metabolic failure | 1.649 (0.763–3.565) | 0.204 |
| Hematologic failure | 1.166 (0.719–1.891) | 0.533 |
| Peripheral artery obstructive disease | 0.948 (0.354–2.538) | 0.915 |
* p < 0.05.
Risk factors for ischemic heart disease in septicemia survivors.
| Univariate Hazard Ratio |
| Multivariate Hazard Ratio |
| |
|---|---|---|---|---|
| New-onset atrial fibrillation | 3.148 (95% C.I.:2.157–4.593) | <0.001 * | 2.836 (95% C.I.: 1.725–4.665) | <0.001 * |
| Age | 1.02 (95% C.I.: 1.014–1.026) | <0.001 * | 1.012 (95% C.I.:1.005–1.018) | 0.001 * |
| Sex (male) | 1.208 (95% C.I.:0.992–1.471) | 0.06 | 1.266 (95% C.I.:1.038–1.545) | 0.02 * |
| Hypertension | 0.885 (95% C.I.:0.801–0.977) | 0.015 * | ||
| Diabetes mellitus | 0.901 (95% C.I.:0.816–0.996) | 0.042 * | ||
| Hyperlipidemia | 0.978 (95% C.I.:0.796–1.202) | 0.831 | ||
| Congestive heart failure | 2.119 (95% C.I.:1.661–2.704) | <0.001 * | 1.633 (95% C.I.:1.253–2.128) | <0.001 * |
| Chronic kidney disease | 2.013 (95% C.I.:1.647–2.462) | <0.001 * | 1.79 (95% C.I.:1.452–2.207) | <0.001 * |
| Cancer | 3.684 (95% C.I.:2.924–4.641) | <0.001 * | 4.361 (95% C.I:3.441–5.527) | <0.001 * |
| Chronic obstructive pulmonary disease | 1.589 (95% C.I.:1.296–1.969) | <0.001 * | 1.37 (95% C.I.:1.09–1.723) | 0.007 * |
| Hospital level | ||||
| Medical center | Reference | |||
| Region hospital | 1.044 (95% C.I.:0.831–1.311) | 0.711 | ||
| Local hospital | 1.091 (95% C.I.:0.845–1.407) | 0.504 | ||
| Area | ||||
| Northern Taiwan | Reference | |||
| Central Taiwan | 0.996 (95% C.I.:0.778–1.277) | 0.978 | ||
| SouthernTaiwan | 1.017 (95% C.I.: 0.8–1.294) | 0.89 | ||
| Eastern Taiwan | 1.064 (95% C.I.:0.699–1.619) | 0.772 | ||
| Outlying islands | 0.87 (0.122–6.214) | 0.89 | ||
| Infection type | ||||
| Pneumonia | 1.096 (95% C.I.:0.84–1.429) | 0.499 | ||
| Urinary tract infection | 0.827 (0.662–1.032) | 0.092 | ||
| Skin infection | 0.655 (95% C.I.:0.403–1.064) | 0.088 | ||
| GI infection | 0.585 (95% C.I.:0.355–0.965) | 0.036 * | ||
| Organ failure | ||||
| Respiratory failure | 1.351 (95% C.I.:1.034–1.764) | 0.027 * | ||
| Circulatory failure | 1.382 (95% C.I.:0.997–1.915) | 0.052 | ||
| Renal failure | 1.613 (95% C.I.:1.16–2.245) | 0.006 * | ||
| Neurologic failure | 0.676 (95% C.I.:0.253–1.81) | 0.436 | ||
| Hepatic failure | 1.237 (95% C.I.:0.679–2.251) | 0.487 | ||
| Metabolic failure | 2.572 (95% C.I.:0.961–6.886) | 0.06 | ||
| Hematologic failure | 1.034 (95% C.I.:0.514–2.082) | 0.925 | ||
| Peripheral artery obstructive disease | 2.074 (95% C.I.:0.775–5.554) | 0.146 |
* p < 0.05.
Major adverse cardiovascular events and new-onset atrial fibrillation by age group.
| Youth | Middle-Aged | Senior | |
|---|---|---|---|
| Major adverse cardiovascular disease | 77 (7.73%) | 245 (19.11%) | 531 (25.97%) |
| Stroke | 1 (0.1%) | 5 (0.39%) | 33 (1.61%) |
| Ischemic heart disease | 43 (4.3%) | 126 (9.83%) | 235 (11.49%) |
| Death | 44 (4.42%) | 158 (12.32%) | 381 (18.63%) |
| New-onset atrial fibrillation | 1 (0.1%) | 7 (0.55%) | 59 (2.89%) |